SCHEMBL25538992

SCHEMBL25538992

CC(C)c1ccc2[nH]c(C(C)C)c(C(C)C)c2c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 2/20 0.56
KDM4E B2RXH2 2/20 0.48
GAA P10253 2/20 0.44
HTR1D P28221 2/20 0.41
MAPT P10636 3/20 0.40
HTT P42858 3/20 0.40
ALDH1A1 P00352 2/20 0.40
UBE2N P61088 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
HTR1B P28222 1/20 0.39
TLR9 Q9NR96 4/20 0.37
TLR8 Q9NR97 4/20 0.37
TLR7 Q9NYK1 4/20 0.37
LMNA P02545 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
EIF4A3 P38919 2/20 0.36
SIRT1 Q96EB6 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21376875 0.84 KIF11 (0.62) KIF11KDM4EGAAHTR1DMAPT
SCHEMBL22479060 0.80 KIF11 (0.46) KIF11KDM4EGAAHTR1DMAPT
SCHEMBL31549973 0.79 KIF11 (0.79) KIF11KDM4EGAAMAPTALDH1A1
SCHEMBL13010630 0.79 KIF11 (0.79) KIF11KDM4EGAAMAPTALDH1A1
SCHEMBL30234429 0.76 CCNB2 (0.56) KIF11KDM4EGAAMAPTHTT
SCHEMBL10280325 0.76 CCNB2 (0.56) KIF11KDM4EGAAMAPTHTT
SCHEMBL22756732 0.76 KIF11 (0.53) KIF11KDM4EGAAHTR1DMAPT
SCHEMBL8977738 0.75 KDM4E (0.54) KIF11KDM4EMAPTALDH1A1L3MBTL1
SCHEMBL19608621 0.74 KIF11 (0.56) KIF11KDM4EGAAHTR1DMAPT
SCHEMBL12789481 0.74 KIF11 (0.65) KIF11KDM4EGAAHTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159573-A1 SMALL MOLECULE STAT PROTEIN DEGRADERS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2023-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159573-A1 SMALL MOLECULE STAT PROTEIN DEGRADERS STAT1, STAT3, STAT5A KIF11 2466/4885KDM4E 672/4885GAA 885/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.